MARCAINE HYDROCHLORIDE W Drug Patent Profile
✉ Email this page to a colleague
When do Marcaine Hydrochloride W patents expire, and what generic alternatives are available?
Marcaine Hydrochloride W is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in MARCAINE HYDROCHLORIDE W is bupivacaine hydrochloride; epinephrine bitartrate. There are twelve drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MARCAINE HYDROCHLORIDE W?
- What are the global sales for MARCAINE HYDROCHLORIDE W?
- What is Average Wholesale Price for MARCAINE HYDROCHLORIDE W?
Summary for MARCAINE HYDROCHLORIDE W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | MARCAINE HYDROCHLORIDE W at DailyMed |
US Patents and Regulatory Information for MARCAINE HYDROCHLORIDE W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 016964-004 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE PRESERVATIVE FREE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 016964-007 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | MARCAINE HYDROCHLORIDE W/ EPINEPHRINE | bupivacaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 016964-008 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
